Table 1.
Baseline characteristics of patients at baseline
| Number (total N = 30) | % | |
|---|---|---|
| Median age (years) | 62 | |
| Range | 42–77 | |
| Missing | 1 | 3.3 |
| Sex | ||
| Male | 26 | 86.7 |
| Female | 4 | 13.3 |
| Median time interval since first diagnosis (months) | 23 | |
| Range | 8–45 | |
| Median time interval since last chemotherapy (months) | 2 | |
| Range | 1–18 | |
| Missing | 2 | 6.7 |
| Median number of previous chemotherapy regimens | 2 | |
| Range | 1–4 | |
| Missing | 2 | 6.7 |
| Median number of previous chemotherapy cycles | 8 | |
| Range | 2–21 | |
| Missing | 6 | 20.0 |
| Location of primary tumor | ||
| Stomach | 13 | 43.3 |
| Gastro-esophageal junction | 17 | 56.7 |
| Histological type of primary tumor | ||
| Adenocarcinoma | 30 | 100 |
| Diffuse | 9 | 30.0 |
| Intestinal | 9 | 30.0 |
| Signet ring | 4 | 13.3 |
| Adenocarcinoma NOS | 8 | 26.7 |
| T-stage | ||
| T1/2 | 7 | 23.3 |
| T3/4 | 13 | 43.3 |
| Missinga | 10 | 33.4 |
| N-stage | ||
| N0 | 4 | 13.3 |
| N+ | 18 | 60.0 |
| Missinga | 8 | 26.7 |
| M-stage | ||
| M0 | 3 | 10.0 |
| M1 | 20 | 66.7 |
| Missinga | 7 | 23.3 |
M metastatasis, N node, NOS not otherwise specified, T tumor
aMissing includes values that could not be determined (i.e., Tx, Gx Nx, Mx)